Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
New AI method predicts gene activity in human cells

New AI method predicts gene activity in human cells

Mutation in ASXL1 gene triggers chain reaction leading to blood disorders

Mutation in ASXL1 gene triggers chain reaction leading to blood disorders

CAR-T cells carry memory of past antigen encounters

CAR-T cells carry memory of past antigen encounters

New approach in fighting leukemia with double-modified natural killer cells

New approach in fighting leukemia with double-modified natural killer cells

Huntsman Cancer Institute joins innovative clinical trials program for blood cancers

Huntsman Cancer Institute joins innovative clinical trials program for blood cancers

Scientists discover key protein that helps cancer cells evade CAR T cell therapy

Scientists discover key protein that helps cancer cells evade CAR T cell therapy

WashU Medicine receives $10.8 million grant to advance blood cancer research

WashU Medicine receives $10.8 million grant to advance blood cancer research

Scientists create blood test to enhance cancer treatment effectiveness

Scientists create blood test to enhance cancer treatment effectiveness

Gene variant in Andean populations could help predict blood cancer treatment outcomes

Gene variant in Andean populations could help predict blood cancer treatment outcomes

Adjuvant anthracycline- plus taxane-based chemotherapy regimen improves survival in high-risk breast cancer patients

Adjuvant anthracycline- plus taxane-based chemotherapy regimen improves survival in high-risk breast cancer patients

Olaparib provides survival benefits for high-risk BRCA-positive breast cancer patients

Olaparib provides survival benefits for high-risk BRCA-positive breast cancer patients

Mayo Clinic researchers advocate for comprehensive TPMT genotyping across ancestries

Mayo Clinic researchers advocate for comprehensive TPMT genotyping across ancestries

New triplet therapies show promise for relapsed and newly diagnosed leukemias

New triplet therapies show promise for relapsed and newly diagnosed leukemias

First-in-class monoclonal antibody shows promise for rare, aggressive hyperinflammatory condition

First-in-class monoclonal antibody shows promise for rare, aggressive hyperinflammatory condition

New advances offer hope for patients with systemic mastocytosis

New advances offer hope for patients with systemic mastocytosis

Novel drug combination shows promise for CLL treatment

Novel drug combination shows promise for CLL treatment

Breakthrough treatment improves survival rates for children with B-ALL

Breakthrough treatment improves survival rates for children with B-ALL

Mapping blood system changes offers new hope for leukemia treatments

Mapping blood system changes offers new hope for leukemia treatments

New collaborative effort aims to cure ALK-positive lung cancer

New collaborative effort aims to cure ALK-positive lung cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.